[HTML][HTML] The current role of sodium-glucose cotransporter 2 inhibitors in type 2 diabetes mellitus management
B Xu, S Li, B Kang, J Zhou - Cardiovascular diabetology, 2022 - Springer
Type 2 diabetes mellitus (T2DM) is a chronic, complex metabolic disease characterized by
chronic hyperglycemia causing from insufficient insulin signaling because of insulin …
chronic hyperglycemia causing from insufficient insulin signaling because of insulin …
The current role of sodium-glucose cotransporter 2 inhibitors in type 2 diabetes mellitus management.
B Xu, S Li, B Kang, J Zhou - Cardiovascular Diabetology, 2022 - search.ebscohost.com
Type 2 diabetes mellitus (T2DM) is a chronic, complex metabolic disease characterized by
chronic hyperglycemia causing from insufficient insulin signaling because of insulin …
chronic hyperglycemia causing from insufficient insulin signaling because of insulin …
The current role of sodium-glucose cotransporter 2 inhibitors in type 2 diabetes mellitus management
B Xu, S Li, B Kang, J Zhou - Cardiovascular Diabetology, 2022 - search.proquest.com
Type 2 diabetes mellitus (T2DM) is a chronic, complex metabolic disease characterized by
chronic hyperglycemia causing from insufficient insulin signaling because of insulin …
chronic hyperglycemia causing from insufficient insulin signaling because of insulin …
[HTML][HTML] The current role of sodium-glucose cotransporter 2 inhibitors in type 2 diabetes mellitus management
B Xu, S Li, B Kang, J Zhou - Cardiovascular …, 2022 - cardiab.biomedcentral.com
Type 2 diabetes mellitus (T2DM) is a chronic, complex metabolic disease characterized by
chronic hyperglycemia causing from insufficient insulin signaling because of insulin …
chronic hyperglycemia causing from insufficient insulin signaling because of insulin …
The current role of sodium-glucose cotransporter 2 inhibitors in type 2 diabetes mellitus management
B Xu, S Li, B Kang, J Zhou - Cardiovascular Diabetology, 2022 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Type 2 diabetes mellitus (T2DM) is a chronic,
complex metabolic disease characterized by chronic hyperglycemia causing from …
complex metabolic disease characterized by chronic hyperglycemia causing from …
The current role of sodium-glucose cotransporter 2 inhibitors in type 2 diabetes mellitus management
B Xu, S Li, B Kang, J Zhou - Cardiovascular diabetology, 2022 - pubmed.ncbi.nlm.nih.gov
Type 2 diabetes mellitus (T2DM) is a chronic, complex metabolic disease characterized by
chronic hyperglycemia causing from insufficient insulin signaling because of insulin …
chronic hyperglycemia causing from insufficient insulin signaling because of insulin …
[HTML][HTML] The current role of sodium-glucose cotransporter 2 inhibitors in type 2 diabetes mellitus management
B Xu, S Li, B Kang, J Zhou - Cardiovascular Diabetology, 2022 - ncbi.nlm.nih.gov
Type 2 diabetes mellitus (T2DM) is a chronic, complex metabolic disease characterized by
chronic hyperglycemia causing from insufficient insulin signaling because of insulin …
chronic hyperglycemia causing from insufficient insulin signaling because of insulin …
The current role of sodium-glucose cotransporter 2 inhibitors in type 2 diabetes mellitus management.
B Xu, S Li, B Kang, J Zhou - Cardiovascular Diabetology, 2022 - go.gale.com
Type 2 diabetes mellitus (T2DM) is a chronic, complex metabolic disease characterized by
chronic hyperglycemia causing from insufficient insulin signaling because of insulin …
chronic hyperglycemia causing from insufficient insulin signaling because of insulin …
The current role of sodium-glucose cotransporter 2 inhibitors in type 2 diabetes mellitus management.
B Xu, S Li, B Kang, J Zhou - Cardiovascular Diabetology, 2022 - europepmc.org
Type 2 diabetes mellitus (T2DM) is a chronic, complex metabolic disease characterized by
chronic hyperglycemia causing from insufficient insulin signaling because of insulin …
chronic hyperglycemia causing from insufficient insulin signaling because of insulin …
[PDF][PDF] The current role of sodium-glucose cotransporter 2 inhibitors in type 2 diabetes mellitus management
B Xu, S Li, B Kang, J Zhou - 2022 - cardiab.biomedcentral.com
Type 2 diabetes mellitus (T2DM) is a chronic, complex metabolic disease characterized by
chronic hyperglycemia causing from insufficient insulin signaling because of insulin …
chronic hyperglycemia causing from insufficient insulin signaling because of insulin …